New therapeutic indications for Cys-LT1 antagonists: Atopic dermatitis and urticaria

Clinical and Experimental Allergy Reviews

Volumn 1, Issue 2, 2001, Pages 156-159

  Friedmann, P S ^a   Perzanowska, M ^a,b   McGuire, C ^a   Nayak, N ^a   Clough, G F ^a   Sampson, A P ^a   Church, M K ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CYSTEINYLLEUKOTRIENE ANTAGONIST; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DRUG INDICATION; DRUG MECHANISM; EOSINOPHIL; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT OUTCOME; URTICARIA;

EID: 0034883610     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2001.00030.x     Document Type: Conference Paper

References (26)

1. Cyclosporin A in atopic dermatitis: Therapeutic response is dissociated from effects on allergic reactions
2. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis
3. Evaluation of the atopy patch test and the cutaneous latephase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema
4. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic-dermatitis and psoriasis
5. Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E2 and leukotriene B4 are present in biologically active concentrations
6. Enhanced synthesis of cysteinyl leukotrienes in atopic-dermatitis
7. Urinary leukotriene E-4 levels in patients with atopic dermatitis
8. Detection of immunoreactive leukotrienes LTC4/D4 in skin-blister fluid after allergen testing in patients with late cutaneous reactions (LCR)
9. Accumulation of leukotriene C4 and histamine in human allergic skin reactions
10. The pattern and kinetics in human-skin of erythema and mediators during the acute and late-phase response (LPR)
11. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis
12. Six area, six sign atopic dermatitis (SAS-SAD) severity score: A simple system for monitoring disease activity in atopic dermatitis
13. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: A study using scanning laser Doppler imaging
14. Measurement of nitric oxide concentration in human skin in vivo using dermal microdialysis
15. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial
16. Comparative efficacy with zafirlukast and low-dose steroids in responding asthmatics on pm beta-agonists
17. Local-effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human-skin
18. Leukotriene E4 release in cold urticaria
19. Leukotriene receptor antagonists in the treatment of chronic idiopathic urticaria
20. Zafirlukast (ACCOLATE (R) in the treatment of chronic idiopathic urticaria - A case series
21. Antileukotrienes in chronic urticaria
22. Leukotrienes and Cytokines in steroid dependent chronic urticaria
23. Successful treatment of chronic urticaria with leukotriene antagonists
24. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria
25. Aspirin-sensitive urticaria: Provocation with a leukotriene receptor antagonist
26. Successful treatment of delayed pressure urticaria with montelukast